Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens.

about

Sex Differences in HIV Infection.Adipocytes impair efficacy of antiretroviral therapy.Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.Weight Gain: A Possible Side Effect of All Antiretrovirals

P2860

Q52674721-4074E885-A3C1-4D33-B089-B022BF599124 Q52720640-F34308B5-BB0A-4735-A01F-1098D177580D Q53691000-BE009FF9-5482-4224-986A-F672F33ECA2A Q58812046-2979B583-965A-497A-B1D4-FD03639DC182

P2860

Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens.

Item

http://www.wikidata.org/entity/Q40076712

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Weight Gain in Persons with HI ...... sfer Inhibitor-based Regimens.

@en

type

Item

label

Weight Gain in Persons with HI ...... sfer Inhibitor-based Regimens.

@en

prefLabel

Weight Gain in Persons with HI ...... sfer Inhibitor-based Regimens.

@en

P1476

Weight Gain in Persons with HI ...... sfer Inhibitor-based Regimens.

@en

P2093

Bryan Shepherd

http://www.w3.org/2001/XMLSchema#string

Carmen Bofill

http://www.w3.org/2001/XMLSchema#string

David W Haas

http://www.w3.org/2001/XMLSchema#string

Jamison Norwood

http://www.w3.org/2001/XMLSchema#string

John R Koethe

http://www.w3.org/2001/XMLSchema#string

Megan Turner

http://www.w3.org/2001/XMLSchema#string

Sally Bebawy

http://www.w3.org/2001/XMLSchema#string

Stephen Raffanti

http://www.w3.org/2001/XMLSchema#string

Timothy R Sterling

http://www.w3.org/2001/XMLSchema#string

Todd Hulgan

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing rates of obesity among HIV-infected persons during the HIV epidemic

Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia.

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.

Metabolic effects of infection on protein and energy status.

Increased plasma gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting.

Weight change after antiretroviral therapy and mortality.

Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.

Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering.

P31

scholarly article

P356

10.1097/QAI.0000000000001525

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Peter Francis Rebeiro

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28825943

http://www.w3.org/2001/XMLSchema#string

P921

weight gain

P932

5680113

http://www.w3.org/2001/XMLSchema#string

Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens.

about

P2860

P2860

Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P921

P932